An outside expert panel for the Food and Drug Administration (FDA) today recommended emergency use authorization (EUA) for Moderna's COVID-19 vaccine, putting the nation on the cusp of having two COVID-19 vaccines and expanding the reach of immunization campaigns.The main question before the group today was whether the benefits outweigh the risks in people ages 18 and older.
The measure passed with 20 yes votes, 0 no votes, and 1 abstention. The FDA usually follows the recommendations of its Vaccines and Related Biological Products Advisory Committee (VRBPAC), and the FDA has signaled that it would quickly make its approval decision.Adm.
Read more on cidrap.umn.edu